GHK-Cu

GHK-Cu

03
Longevity and skin-regeneration peptide · Copper biopeptide
99% Purity Anti-Aging Regeneration

GHK-Cu is a tripeptide (glycyl-L-histidyl-L-lysine) bound to a copper atom that occurs naturally in human plasma and declines with age. It acts as a tissue-repair signal, modulating the expression of more than 4000 genes related to wound healing, collagen remodeling, antioxidation and regeneration. The blue-purple color of the powder is characteristic and confirms the integrity of the copper complex.

Key Benefits
Increases collagen and elastin
Improves skin firmness and texture
Accelerates wound healing
Reduces systemic inflammation
Stimulates hair growth
Antioxidant and anti-aging action
Mechanism of Action
GHK-Cu acts as a tissue-repair signal, modulating the expression of more than 4000 genes related to wound healing, collagen remodeling, antioxidation and regeneration. The copper bound to the tripeptide is essential for activating the collagen- and elastin-synthesis pathways.
Protocol

Reconstitution & Usage Protocol

Only chill the water 3 minutes before reconstituting the peptide. Do not prepare with very cold water, because it can freeze, lose effect or be damaged.
1Reconstitution
1 vial of GHK-Cu 50 mg (blue-purple powder) · 1 vial of bacteriostatic water · U-100 insulin syringe (preferably a very fine 31G–32G needle) · alcohol wipes.
  1. Bring the vial to room temperature for 10–15 minutes.
  2. Disinfect the rubber caps with an alcohol wipe.
  3. Draw 3 mL of bacteriostatic water with a 3 mL syringe.
  4. Inject the water slowly down the inner wall of the vial. The blue-purple powder should dissolve into a translucent blue solution.
  5. Do not shake. Swirl gently for 30–60 seconds until fully dissolved.
Label with the date and refrigerate (2–8 °C). Protect from light. Stable for 30 days.
2Concentration & Dosing
Reconstituting 50 mg in 3 mL → 16.66 mg/mL ≈ 166.6 mcg per IU.
Target doseUnitsVolume
1 mg (low)6 IU0.06 mL
2 mg (standard)12 IU0.12 mL
3 mg (high)18 IU0.18 mL
Universal formula: IU = (dose in mcg ÷ 166.6)
3Application
Route
Subcutaneous (systemic and aesthetic effect) or topical formulated at 2–5%.
Frequency
Once a day, preferably at night.
Cycle
4–8 weeks with a 2-week rest.
  • To minimize pain (recommended): use a very fine needle (31G or 32G), inject very slowly (takes 8–10 seconds), apply in areas with fatty tissue (abdomen, thigh), and rotate the injection site with each application.
  • Warm the loaded dose for about 2–3 minutes in your hand before injecting — cold intensifies the burning sensation of the copper.
  • Gently massage the area for ~40 seconds post-injection to disperse the peptide and reduce local discomfort.
  • Frequent combination: with BPC-157 and TB-500 (Glow blend) for aesthetic synergy.
Solo poner a enfriar el agua 3 minutos antes de reconstituir el péptido. No preparar con agua muy fría, porque se puede congelar, perder efecto o dañarse.
1Reconstitución
1 vial de GHK-Cu 50 mg (polvo azul-púrpura) · 1 vial de agua bacteriostática · jeringa de insulina U-100 (preferiblemente aguja 31G–32G muy fina) · toallitas de alcohol.
  1. Atemperar el vial a temperatura ambiente 10–15 minutos.
  2. Desinfectar las tapas de goma con toallita de alcohol.
  3. Cargar 3 mL de agua bacteriostática con jeringa de 3 mL.
  4. Inyectar el agua lentamente por la pared interior del vial. El polvo azul-púrpura debe disolverse en una solución azul traslúcida.
  5. No agitar. Girar suavemente 30–60 segundos hasta disolución completa.
Etiquetar con fecha y refrigerar (2–8 °C). Proteger de la luz. Estable 30 días.
2Concentración y dosis
Reconstituyendo 50 mg en 3 mL → 16,66 mg/mL ≈ 166,6 mcg por UI.
Dosis objetivoUnidadesVolumen
1 mg (baja)6 UI0,06 mL
2 mg (estándar)12 UI0,12 mL
3 mg (alta)18 UI0,18 mL
Fórmula universal: UI = (dosis en mcg ÷ 166,6)
3Aplicación
Vía
Subcutánea (efecto sistémico y estético) o tópica formulada al 2–5%.
Frecuencia
1 vez al día, preferiblemente en la noche.
Ciclo
4–8 semanas con descanso de 2 semanas.
  • Para minimizar dolor (recomendado): usar aguja muy fina (31G o 32G), inyectar muy lentamente (toma 8–10 segundos), aplicar en zonas con tejido graso (abdomen, muslo), y rotar sitio de inyección en cada aplicación.
  • Atemperar la dosis cargada unos 2–3 minutos en la mano antes de inyectar — el frío intensifica la sensación de ardor del cobre.
  • Masajear suavemente la zona durante ~40 segundos post-inyección para dispersar el péptido y reducir molestia local.
  • Combinación frecuente: con BPC-157 y TB-500 (blend Glow) para sinergia estética.
Mettre l'eau à refroidir seulement 3 minutes avant de reconstituer le peptide. Ne pas préparer avec de l'eau très froide, car elle peut geler, perdre son effet ou s'abîmer.
1Reconstitution
1 flacon de GHK-Cu 50 mg (poudre bleu-violet) · 1 flacon d'eau bactériostatique · seringue à insuline U-100 (de préférence aiguille 31G–32G très fine) · lingettes d'alcool.
  1. Laisser le flacon revenir à température ambiante 10–15 minutes.
  2. Désinfecter les bouchons en caoutchouc avec une lingette d'alcool.
  3. Prélever 3 mL d'eau bactériostatique avec une seringue de 3 mL.
  4. Injecter l'eau lentement le long de la paroi interne du flacon. La poudre bleu-violet doit se dissoudre en une solution bleue translucide.
  5. Ne pas agiter. Faire tourner doucement 30–60 secondes jusqu'à dissolution complète.
Étiqueter avec la date et réfrigérer (2–8 °C). Protéger de la lumière. Stable 30 jours.
2Concentration et dosage
En reconstituant 50 mg dans 3 mL → 16,66 mg/mL ≈ 166,6 mcg par UI.
Dose cibleUnitésVolume
1 mg (faible)6 UI0,06 mL
2 mg (standard)12 UI0,12 mL
3 mg (élevée)18 UI0,18 mL
Formule universelle : UI = (dose en mcg ÷ 166,6)
3Application
Voie
Sous-cutanée (effet systémique et esthétique) ou topique formulée à 2–5 %.
Fréquence
1 fois par jour, de préférence le soir.
Cycle
4–8 semaines avec un repos de 2 semaines.
  • Pour minimiser la douleur (recommandé) : utiliser une aiguille très fine (31G ou 32G), injecter très lentement (prend 8–10 secondes), appliquer dans des zones à tissu adipeux (abdomen, cuisse), et alterner le site d'injection à chaque application.
  • Réchauffer la dose chargée environ 2–3 minutes dans la main avant d'injecter — le froid intensifie la sensation de brûlure du cuivre.
  • Masser doucement la zone pendant ~40 secondes après l'injection pour disperser le peptide et réduire la gêne locale.
  • Combinaison fréquente : avec BPC-157 et TB-500 (blend Glow) pour une synergie esthétique.

Open dosage calculator →

Research Highlights

Research Highlights

FAQ

Frequently Asked Questions

What is GHK-Cu and why does it have a blue-purple color?

GHK-Cu is a copper-bound tripeptide (glycyl-L-histidyl-L-lysine) found naturally in human plasma that declines with age and is studied as a tissue-repair signal modulating over 4000 genes. The characteristic blue-purple color of the powder reflects the copper complex and is used to confirm its integrity. It is supplied strictly for in-vitro and laboratory research.

How is the 50 mg vial reconstituted and what concentration results?

In published handling protocols, 50 mg is reconstituted in 3 mL of bacteriostatic water injected slowly down the vial wall, yielding 16.66 mg/mL (≈ 166.6 mcg per IU). The solution should not be shaken but swirled gently for 30–60 seconds until the blue-purple powder forms a translucent blue solution. These are laboratory measurement parameters, not a human dosing recommendation.

Why must the water and the loaded dose be temperature-managed?

Water should only be chilled for 3 minutes before reconstitution because very cold water can freeze the peptide, reduce its effect or damage it. Likewise, the loaded dose is warmed for about 2–3 minutes in the hand before application because cold intensifies the burning sensation associated with the copper. These steps protect compound integrity in research handling.

Is GHK-Cu studied in combination with other peptides?

In research design it is frequently paired with BPC-157 and TB-500 (the Glow blend) to investigate aesthetic and regenerative synergy. Typical study cycles run 4–8 weeks with a 2-week rest, and it may be applied subcutaneously or topically formulated at 2–5%. Any such pairing is an experimental design choice for controlled laboratory research only and is not a human-use recommendation.

Related Compounds

Related Compounds

← Back to full catalog